Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed
- PMID: 2754630
- DOI: 10.1016/0022-3956(89)90019-8
Plasma levels of nortriptyline and 10-hydroxynortriptyline and treatment-related electrocardiographic changes in the elderly depressed
Abstract
Thirty-one elderly depressed patients were treated for seven weeks with nortriptyline with plasma levels kept between 50-180 ng/ml. Electrocardiograms were taken at the third and seventh weeks of treatment. There were significant increases in the PR interval, QTc interval, and heart rate from before and after treatment. However, there were no consistent correlations between electrocardiographic changes during treatment and plasma levels of nortriptyline, 10-hydroxynortriptyline and either of its two isomers (E-10-hydroxynortriptyline, Z-10-hydroxynortriptyline). Increased QRS duration after seven weeks of treatment was correlated with daily dose of nortriptyline.
Similar articles
-
Electrocardiographic changes with nortriptyline and 10-hydroxynortriptyline in elderly depressed outpatients.J Clin Psychopharmacol. 1988 Dec;8(6):402-8. J Clin Psychopharmacol. 1988. PMID: 3069881 Clinical Trial.
-
Plasma 10-hydroxynortriptyline and ECG changes in elderly depressed patients.Am J Psychiatry. 1985 Jul;142(7):866-8. doi: 10.1176/ajp.142.7.866. Am J Psychiatry. 1985. PMID: 4014510
-
10-Hydroxynortriptyline and treatment effects in elderly depressed patients.J Neuropsychiatry Clin Neurosci. 1989 Spring;1(2):176-80. doi: 10.1176/jnp.1.2.176. J Neuropsychiatry Clin Neurosci. 1989. PMID: 2521060 Clinical Trial.
-
Nortriptyline pharmacokinetics and plasma levels: implications for clinical practice.J Clin Psychiatry. 1985 Oct;46(10):418-24. J Clin Psychiatry. 1985. PMID: 3900052 Review.
-
E-10-hydroxynortriptyline: effects and disposition of a potential novel antidepressant.Psychopharmacol Ser. 1989;7:52-9. doi: 10.1007/978-3-642-74430-3_6. Psychopharmacol Ser. 1989. PMID: 2687868 Review. No abstract available.
Cited by
-
Evaluating the risk of QTc prolongation associated with antidepressant use in older adults: a review of the evidence.Ther Adv Drug Saf. 2018 Jun;9(6):297-308. doi: 10.1177/2042098618772979. Epub 2018 May 4. Ther Adv Drug Saf. 2018. PMID: 29854391 Free PMC article. Review.
-
Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients.Eur J Clin Pharmacol. 2020 Jan;76(1):73-80. doi: 10.1007/s00228-019-02766-2. Epub 2019 Oct 23. Eur J Clin Pharmacol. 2020. PMID: 31641787
-
The Role of Metabolites of Antidepressants in the Treatment of Depression.CNS Drugs. 1997 Apr;7(4):273-312. doi: 10.2165/00023210-199707040-00003. CNS Drugs. 1997. PMID: 27520753 Review.
-
Cardiovascular effects of fluvoxamine and maprotiline in depressed patients.Eur Arch Psychiatry Clin Neurosci. 1995;246(1):1-6. doi: 10.1007/BF02191808. Eur Arch Psychiatry Clin Neurosci. 1995. PMID: 8773212 Clinical Trial.
-
Antidepressants for depressed elderly.Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD003491. doi: 10.1002/14651858.CD003491.pub2. Cochrane Database Syst Rev. 2006. PMID: 16437456 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials